Prospective Clinicogenomic Program
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Non - Small Cell Lung Cancer NSCLC
- Small Cell Lung Cancer (SCLC)
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04180176
- Collaborators
- Flatiron Health, Inc.; Foundation Medicine, Inc.
- Investigators
- Study Director: Clinical Trials Hoffmann-La Roche
Get Well Soon